The Living Guidelines: UA/NSTEMI Recommendations for Identification of Patients at Risk of UA/NSTEMI Polling Results for CLASS I Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class I Guidelines
1. Primary care providers should evaluate the presence and status of control of major risk factors for coronary heart disease (CHD) for all patients at regular intervals (approximately every 3 to 5 years). (Level of Evidence: C)

 Class I Recommendation 1 for Identification of Patients at Risk of UA/NSTEMI should be: CLASS I CLASS IIa CLASS IIb CLASS III 2. Ten year risk (National Cholesterol Education Program [NCEP] global risk) of developing symptomatic CHD should be calculated for all patients who have 2 or more major risk factors to assess the need for primary prevention strategies. (Level of Evidence: B)

 Class I Recommendation 2 for Identification of Patients at Risk of UA/NSTEMI should be: CLASS I CLASS IIa CLASS IIb CLASS III 3. Patients with established CHD should be identified for secondary prevention efforts, and patients with a CHD risk equivalent (e.g., atherosclerosis in other vascular beds, diabetes mellitus, chronic kidney disease, or 10 year risk >20% as calculated by Framingham equations) should receive equally intensive risk factor intervention as those with clinically apparent CHD. (Level of Evidence: A)

 Class I Recommendation 3 for Identification of Patients at Risk of UA/NSTEMI should be: CLASS I CLASS IIa CLASS IIb CLASS III